KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Change in Account Payables (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Change in Account Payables for 17 consecutive years, with $547.5 million as the latest value for Q4 2025.

  • Quarterly Change in Account Payables rose 3.91% to $547.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.1 billion through Dec 2025, changed 0.03% year-over-year, with the annual reading at $2.1 billion for FY2025, 0.03% changed from the prior year.
  • Change in Account Payables for Q4 2025 was $547.5 million at Bio-Rad Laboratories, up from $517.5 million in the prior quarter.
  • The five-year high for Change in Account Payables was $620.3 million in Q2 2023, with the low at $446.4 million in Q3 2024.
  • Average Change in Account Payables over 5 years is $544.7 million, with a median of $538.8 million recorded in 2021.
  • The sharpest move saw Change in Account Payables skyrocketed 30.05% in 2022, then dropped 18.67% in 2024.
  • Over 5 years, Change in Account Payables stood at $530.0 million in 2021, then increased by 14.62% to $607.5 million in 2022, then decreased by 14.68% to $518.3 million in 2023, then rose by 1.65% to $526.9 million in 2024, then rose by 3.91% to $547.5 million in 2025.
  • According to Business Quant data, Change in Account Payables over the past three periods came in at $547.5 million, $517.5 million, and $505.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.